AI-powered Echocardiography analysis

The EchoGo cloud-based analysis platform will revolutionize how you detect and diagnose heart disease.

Request Demo

Zero variability analysis

EchoGo uses ground-breaking machine learning and patented artificial intelligence to more accurately automate left ventricular cardiac volumes, ejection fraction and cardiac strain. It enables physicians everywhere to use echocardiography – the least invasive and most accessible cardiac imaging modality – to diagnose heart failure and coronary artery disease earlier, faster, and in more people.

Combined-report-1

 

EchoGo LV Volumes

LV Cardiac Volumes

Accurately track endocardial boundaries and measure left ventricular (LV) volumes for end-systolic and end-diastolic frames.

EchoGo-close-up-2-v3

LV Ejection Fraction

Auto report left ventricular ejection fraction (LVEF), the most commonly used measure of systolic function, with zero operator variability. Assess the severity of  systolic function with the same accuracy every time.

EchoGo-close-up-3-v2

LV Cardiac Strain

Fully automate the measurements of global longitudinal strain (GLS) and regional strain (RS) at scale with zero variability across your enterprise. Cardiac strain is a a powerful diagnostic indice for heart failure, cardio-toxicity, cardio myopathy, amyloid, and other forms of cardiac disease.

Eliminate Variability with EchoGo

Learn how EchoGo completely eliminates the subjectivity and variability that has challenged Echocardiography.

Download WhitePaper
Seamless Workflow Integration. Rapid Innovation. The highest levels of security.

Rapid Innovation through the cloud

EchoGo is hosted on Microsoft Azure cloud infrastructure and connects directly to your practice's image repository (PACS) or DICOM image exchange platform. Data is analyzed remotely through the cloud through a secure encrypted connection. EchoGo’s report is automatically returned to the preferred destination for reading by the cardiologist. EchoGo includes embedded security (ISO 27001), data sovereignty and compliance to the highest medical device standards (ISO 13485).
v14

 

Zero-Variability-image-1

Zero Variability

Because of the revolutionary use of AI to automate the entire echo analysis pathway, EchoGo provides zero variability analysis for  sonographers and cardiologists.

Fast-Results-image

Fast Echo Analysis

EchoGo is the only echocardiography analysis solution that eliminates all the manual steps, including view classification, contouring, cycle selection and extraction, and quantification of diagnostic and prognostic Indicators.

EchoGo Predicts Outcomes

Predicts Outcomes

Ultromics maintains exclusive access to one of the largest outcome-based datasets in the world.  The unique and patented architecture has been proven to produce measurements so accurate and precise that they can predict patient outcomes. 

"EchoGo was proven to predict cardiac outcomes – where the status quo manual methods could not".

Game changing 2021 study from WASE.

Explore Study

With EchoGo

vendor-neautral-white (1)-2

Vendor Agnostic

Green Line

Extend the useful life of your existing Echo infrastructure by connecting EchoGo’s cloud-based analysis.

Fully-managed-in-the-cloud-1

Cloud-based SaaS

Green Line

Always have the latest innovation and capability.

Zero-click-white

No Clicks and No Training

Green Line

EchoGo fully automates advanced analysis with no human interaction, saving up to 25% of an allotted Echo study time.

Dollar-icon (1)

Immediate ROI

Green Line

No capital outlays + No upfront costs + new reimbursement = Immediate ROI.

security-shield-white

Industry leading IT Security & Privacy​

Green Line

ISO 27001, ISO 9001, HIPAA​.

patient-heart-icon

Better Outcomes

Green Line

Precision and accuracy proven to be predictive of outcomes.

Improve your Echo Lab Performance 

zero-variability-white (2)

Eliminate Subjectivity & Variability​

Analysis takes time and experience to get optimal results. EchoGo provides accurate and precise analysis - regardless of equipment, staff skill and experience - derived through robust AI and deep neural networks.

rapid-analysis

Improve Efficiency & Throughput

Echo requirements are growing in complexity, but allotted study times are staying the same. EchoGo can automate advanced LV analysis and save up to 25% of your study time. 

knoweldge-base-icon

Access the Latest Technology

On-premise technology can quickly become obsolete, and training and maintenance is time consuming and expensive. EchoGo operates in the cloud, so you always have the latest innovation. There is no special training or manual software interaction required.

EchoGo is now reimbursable

EchoGo more than pays for itself. Find out more about the new Strain reimbursement code +93356.

Contact us
No physical software. No maintenance. No training. No Vendor Lock.

EchoGo on Microsoft Azure

Learn how EchoGo uses the Microsoft Azure cloud to provide rapid and constant innovation that maximizes the capabilities of your existing Echo infrastructure with seamless workflow integration without physical software in your practice or training required by your staff.

Download WhitePaper
Microsoft-Azure-banner-v2

Performance testing for regulatory approval

Accredited experts compared EchoGo with a predicate AI device using manual interaction. Hundreds of echo studies were processed and compared. EchoGo produced 0% variability in measuring Left Ventricular Ejection Fraction, LV Volumes and GLS between operators, providing better precision and excellent reliability. Experts using the traditional predicate software produced a high level of inter- and intra- operator variability. 

Explore Validation
Inter-Variability-Graph-Higher-Res-2

See the latest Validation and Research

JASE-1

EchoGo Predicts Cardiac Outcomes

Lead authors, Dr. Federico Asch and Dr. Roberto Lang, discuss with Ultromics CTO, Gary Woodward, the outcomes of the WASE-COVID trial, a multi-center study from the The World Alliance Societies of Echocardiography using artificial intelligence to predict Cardiac outcomes in COVID-19 patients.

ASE 2021 Abstract 1 Post

AI-Driven LV Assessment reduces variability

Ultromics AI eliminates operator variability in analyzing Echocardiograms. Learn how Ultromics AI’s zero variability echo analysis unlocks the prognostic power of Echo.

Explore Validation

Solutions for Health Systems, Private Practice, and Imaging Centers

See how our customers are benefiting from EchoGo.

Medstar Health

MedStar Health

EchoGo AI derived heart measurements were able to predict COVID-19 mortality, stated in a new international study supported in partnership by the American Society of Echocardiography (ASE), MedStar Health, University of Chicago, and Ultromics.

Jericho-Imaging

Jericho Speciality Imaging

EchoGo is providing physicians with AI-powered Strain analysis on more than a thousand echocardiography exams performed each month, acquired at multiple locations throughout greater Long Island, United States. Myocardial strain is a highly valuable measure used to quantifying left ventricular (LV) function. 

Explore Customer Stories

Selecting a central echo analysis solution was key for us. A huge advantage of using Ultromics’ software was that studies could be easily automated and moved around by all of our Core labs across the world. DICOM data could be securely de-identified and sent up and processed in the cloud and accessed from any location.

Roberto M Lang, Professor of Medicine in the Section of Cardiology, University of Chicago Medical Center.

Ultromics’ AI platform was enormous value in the recent WASE study. It was able to predict patient mortality in the COVID population, when manual analysis could not. The platform was able to almost completely eliminate variability between operators, this lower variability of measurements led to a higher predictive value.

Dr. Federico Miguel Asch, Director of the Echocardiography Core Lab at MedStar Health Research Institute.

AI services like EchoGo can help automate time-consuming, manual analysis required by doctors when diagnosing heart disease - identifying disease faster, reducing patient backlog
and helping to save lives.

Indra Joshi, Director of AI for NHSX.

Ready to connect?

Begin the journey to diagnosing patients accurately, earlier, and at lower costs.

Connect now